KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesCurrent TaxesGoodwillGoodwill & IntangiblesIntangiblesLiabilities and Shareholders EquityLong-Term InvestmentsMinority InterestNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityNon-Current Deferred Tax LiabilityOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)ReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShares OutstandingShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Equity IncomeGross ProfitIncome from Continuing OperationsIncome from Non-Controlling InterestsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeNon Operating Investment IncomeNon Operating Investment IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Weighted Average)Tax ProvisionsTax RateTax Rate
Others
Accumulated Depreciation & AmortizationAccumulated Depreciation & AmortizationCost of RevenueDepreciation & Amortization (IS)EBIATGross ProfitLeasesLoans and Notes ReceivablesLong-Term Debt IssuancesLong-Term Debt RepaymentsMachine, Furnitures, Fixtures & OtherNon-Current ReceivablesOther Gross PP&E AdjustmentsOther Gross PP&E AdjustmentsProperty, Plant & Equipment (Gross)Property, Plant & Equipment (Gross)Receivables - NetReceivables - OtherReceivables RefundsShares OutstandingShares Outstanding
Ratios

Astrana Health (ASTH) Shares Outstanding (2016 - 2025)

Astrana Health (ASTH) has disclosed Shares Outstanding for 15 consecutive years, with $48.9 million as the latest value for Q4 2025.

  • Quarterly Shares Outstanding rose 1.99% to $48.9 million in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $48.9 million through Dec 2025, up 1.99% year-over-year, with the annual reading at $48.9 million for FY2025, 1.99% up from the prior year.
  • Shares Outstanding hit $48.9 million in Q4 2025 for Astrana Health, down from $49.4 million in the prior quarter.
  • In the past five years, Shares Outstanding ranged from a high of $49.4 million in Q3 2025 to a low of $42.6 million in Q1 2021.
  • Historically, Shares Outstanding has averaged $46.5 million across 5 years, with a median of $46.6 million in 2022.
  • Biggest five-year swings in Shares Outstanding: increased 21.86% in 2021 and later rose 0.58% in 2023.
  • Year by year, Shares Outstanding stood at $44.6 million in 2021, then grew by 4.36% to $46.6 million in 2022, then increased by 0.58% to $46.8 million in 2023, then rose by 2.32% to $47.9 million in 2024, then increased by 1.99% to $48.9 million in 2025.
  • Business Quant data shows Shares Outstanding for ASTH at $48.9 million in Q4 2025, $49.4 million in Q3 2025, and $49.1 million in Q2 2025.